RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 763.00
-26.00 (-3.30%)
May 12, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 19.86 billion as of May 12, 2026. Its market cap has increased by 142.69% in one year.
Market Cap
19.86B
Enterprise Value
19.52B
Revenue
3.98B
Ranking
n/a
PE Ratio
67.17
Stock Price
763.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 19.86B, a decrease of -0.20%. That is a compound annual growth rate of -0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 20.54B | -16.85% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 23.88B |
| AnGes | 21.01B |
| StemRIM | 18.80B |
| Stella Pharma | 18.57B |
| Renascience | 17.33B |
| ReproCELL | 16.54B |
| CanBas | 13.05B |
| Immuno-Biological Laboratories | 13.00B |